Virgili, AC, Salazar, J, Gallardo, A, López-Pousa, A, Terés, R, Bagué, S, Orellana, R, Fumagalli, C, Mangues, R, Alba-Castellón, L, Unzueta, U, Casanova, I, Sebio, A. CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas. Diagnostics. 2024; 14(11)DOI:10.3390/diagnostics14111195. PMID:38893721. IF:3.300(Q1/2D).

Cullell, BM, Manrique, ACV, Piedra, A, Fumagalli, C, Mateo, FJP, Serda, PC, Mirallas, O, Martínez, E, Trujillo, JC, Belda-Sanchis, J, Szafranska, J, Paez, D. Immune phenotypes and histological growth patterns in resected lung metastasis of colorectal cancer patients to assess prognosis. ANNALS OF ONCOLOGY. 2024; 35DOI:10.1016/j.annonc.2024.05.133. PMID:. IF:65.400(Q1/1D).

Conde, E, Hernandez, S, Carrillo, JLR, Martinez, R, Alonso, M, Curto, D, Jimenez, B, Caminoa, A, Benito, A, Garrido, P, Clave, S, Arriola, E, Esteban-Rodriguez, I, De Castro, J, Sansano, I, Felip, E, Rojo, F, Dómine, M, Abdulkader, I, Garcia-Gonzalez, J, Teixido, C, Reguart, N, Compañ, D, Insa, A, Mancheño, N, Palanca, S, Juan-Vidal, O, Baixeras, N, Nadal, E, Cebollero, M, Calles, A, Martin, P, Salas, C, Provencio, M, Aranda, I, Massuti, B, Lopez-Vilaro, L, Majem, M, Paz-Ares, L, Lopez-Rios, F. RET Fusion Testing in Patients With NSCLC: The RETING Study. Jto Clinical And Research Reports. 2024; 5(4)DOI:10.1016/j.jtocrr.2024.100653. PMID:38525319. IF:(Q/D).

Gronchi, A, Palmerini, E, Quagliuolo, V, Broto, JM, Pousa, AL, Grignani, G, Brunello, A, Blay, JY, Tendero, O, Beveridge, RD, Ferraresi, V, Lugowska, I, Pizzamiglio, S, Verderio, P, Fontana, V, Donati, DM, Palassini, E, Sanfilippo, R, Bianchi, G, Bertuzzi, A, Morosi, C, Pasquali, S, Stacchiotti, S, Bagué, S, Coindre, JM, Miceli, R, Dei Tos, AP, Casali, PG. Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG). JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(8)DOI:10.1200/JCO.23.00908. PMID:38232337. IF:41.900(Q1/1D).

Arqueros, C, Gallardo, A, Vidal, S, Osuna-Gómez, R, Tibau, A, Bell, OL, Cajal, T, Lerma, E, Lobato-Delgado, B, Salazar, J, Barnadas, A. Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(5)DOI:10.3390/ijms25052627. PMID:38473874. IF:4.900(Q1/3D).

Angelo, ED, Espinosa, I, Wang, AH, Kingsley, L, Nasr, S, Zdravkovic, S, Howitt, B, Prat, J. A Clinicopathologic and Immunohistochemical Analysis of 46 Uterine Mesenchymal Tumors Including Conventional Adenosarcomas, Atypical Uterine Polyps and Other Related Sarcomas. LABORATORY INVESTIGATION. 2024; 104(3)DOI:. PMID:. IF:4.200(Q1/1D).

Espinosa, I, D'Angelo, E, Gallardo, A, Lee, CH, Koebel, M, Prat, J. Loss of Expression of ARID1a and PBRM1 Proteins Is Associated with Poor Prognosis in Mullerian Adenosarcomas. LABORATORY INVESTIGATION. 2024; 104(3)DOI:. PMID:. IF:4.200(Q1/1D).

De Leo, A, Ceccarelli, C, Grillini, M, de Biase, D, Tallini, G, Espinosa, I, Koebel, M, Lee, CH. Tumor Microenvironment in Dedifferentiated and Undifferentiated Endometrial Carcinomas: The Emerging Role of Spatial Cancer-Immunophenotypes and HLA Class I Expression. LABORATORY INVESTIGATION. 2024; 104(3)DOI:. PMID:. IF:4.200(Q1/1D).

Álamo P., Parladé E., Favaro, MTP, Gallardo A., Mendoza R., Ferreira, LCS, Roher N., Mangues R., Villaverde A., Vázquez E.. Probing the Biosafety of Implantable Artificial Secretory Granules for the Sustained Release of Bioactive Proteins. ACS Applied Materials & Interfaces. 2023; 15(33)DOI:10.1021/acsami.3c08643. PMID:37614001. IF:8.500(Q1/2D).

Marti-Aguado, D, Gougol, A, Gomez-Medina, C, Jamali, A, Abo-Zed, A, Morales-Arraez, D, Jimenez-Sosa, A, Burns, K, Bawa, A, Hernandez, A, Pujol, C, Alvarado-Tapias, E, Szafranska, J, Chiu, WK, Villagrasa, A, Ventura-Cots, M, Gandicheruvu, H, Lluch, P, Chen, HW, Rachakonda, V, Duarte-Rojo, A, Bataller, R. Prevalence and clinical impact of alcohol withdrawal syndrome in alcohol-associated hepatitis and the potential role of prophylaxis: a multinational, retrospective cohort study. Eclinicalmedicine. 2023; 61DOI:10.1016/j.eclinm.2023.102046. PMID:37415844. IF:9.600(Q1/1D).

Barrabes-Torrella, C, Arandes-Marcocci, J, Armillas-Lliteras, L, Posada-Caez, RA, Koptseva, I, Fumagalli, C, Pinol-Ballus, D, Salleras-Redonnet, M. Sarcomatoid transformation of a basal cell carcinoma following treatment with hedgehog inhibitors. BRITISH JOURNAL OF DERMATOLOGY. 2023; 189(4)DOI:10.1093/bjd/ljad206. PMID:37378960. IF:11.000(Q1/1D).

Barca, EG, Tomas-Roca, L, Esteve, A, Rodriguez, M, Gato, L, Alonso-Alonso, R, Garcia-Sancho, AM, Cordoba, R, Monter-Rovira, A, Bastos-Oreiro, M, Burgues, JMB, Sayas, MJ, Alegria, MCV, Sanchez-Blanco, JJ, Pellicer, MR, Henriquez, HDL, de Ona, R, Cabezudo, ME, Infante, MS, Hernandez, JAQ, Sanz-Pamplona, R, Blanco, O, Mozos, A, Climent, F, Piris, MA. Extranodal natural killer/T-cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets. AMERICAN JOURNAL OF HEMATOLOGY. 2023; 98(6)DOI:10.1002/ajh.26904. PMID:36882876. IF:10.100(Q1/1D).

Navarro-Perez, M, Estadella, I, Benavente-Garcia, A, Orellana-Fernandez, R, Petit, A, Ferreres, JC, Felipe, A. The Phosphorylation of Kv1.3: A Modulatory Mechanism for a Multifunctional Ion Channel. Cancers. 2023; 15(10)DOI:10.3390/cancers15102716. PMID:37345053. IF:4.500(Q1/3D).

Espinosa, I, D'Angelo, E, De Brot, L, Prat, J. Malignant rhabdoid tumors of the vulva versus epithelioid sarcomas: a clinicopathologic, immunohistochemical, and molecular genetics study. HUMAN PATHOLOGY. 2023; 135DOI:10.1016/j.humpath.2023.02.006. PMID:36863690. IF:2.700(Q2/4D).

Sanchez-Moral, L, Paul, T, Martori, C, Font-Diaz, J, Sanjurjo, L, Aran, G, Tellez, E, Blanco, J, Carrillo, J, Ito, M, Tuttolomondo, M, Ditzel, HJ, Fumagalli, C, Tapia, G, Sidorova, J, Masnou, H, Fernandez-Sanmartin, MA, Lozano, JJ, Vilaplana, C, Rodriguez-Cortes, A, Armengol, C, Valledor, AF, Kremer, L, Sarriasa, MR. Macrophage CD5L is a target for cancer immunotherapy. EBioMedicine. 2023; 91DOI:10.1016/j.ebiom.2023.104555. PMID:37054630. IF:9.700(Q1/1D).

Zampacorta, C, Pasciuto, MP, Ferro, B, Lucidi, A, Maestro, AS, Espinosa, I, D'Angelo, E, Prat, J. Placental site trophoblastic tumor (PSTT): a case report and review of the literature. Pathologica. 2023; 115(2)DOI:10.32074/1591-951X-873. PMID:37114629. IF:(Q/D).

Frezza A.M., Stacchiotti S., Chibon F., Coindre, JM, Italiano A., Romagnosa C., Bagué S., Dei Tos A.P., Braglia L., Palmerini E., Quagliuolo V., Broto J.M., Pousa, AL, Grignani G., Brunello A., Blay, JY, Beveridge R.D., Lugowska I., Lesluyes T., Maestro R., Merlo F.D., Casali P.G., Gronchi A.. CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study. Cancer Medicine. 2023; 12(2)DOI:10.1002/cam4.5015. PMID:35848358. IF:2.900(Q2/5D).

Medina-Gutiérrez E., García-León A., Gallardo A., Álamo P., Alba-Castellón L., Unzueta U., Villaverde A., Vázquez E., Casanova I., Mangues R.. Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models. Cancers. 2023; 15(1)DOI:10.3390/cancers15010085. PMID:36612081. IF:4.500(Q1/3D).

Cosio B.G., Shafiek H., Iglesias A., Mosteiro M., Gonzalez-Piñeiro A., Rodríguez M., García-Cosío M., Busto E., Martin J., Mejías L., Benito A., López Vilaro L., Gómez C.. Validation of a Pathological Score for the Assessment of Bronchial Biopsies in Severe Uncontrolled Asthma: Beyond Blood Eosinophils. ARCHIVOS DE BRONCONEUMOLOGIA. 2023; 59(8)DOI:10.1016/j.arbres.2023.05.014. PMID:37414638. IF:8.700(Q1/1D).

Gené M., Cuatrecasas M., Amat I., Veiga J.A., Fernández Aceñero M.J., Fusté Chimisana V., Tarragona J., Jurado I., Fernández-Victoria R., Martínez Ciarpaglini C., Alenda González C., Zac C., Ortega de la Obra P., Fernández-Figueras M.T., Esteller M., Musulen E.. Alterations in p53, Microsatellite Stability and Lack of MUC5AC Expression as Molecular Features of Colorectal Carcinoma Associated with Inflammatory Bowel Disease. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(10)DOI:10.3390/ijms24108655. PMID:37240002. IF:4.900(Q1/3D).